key: cord-1017100-jucs49di
authors: Kerr, J. R.; Schneider, C. R.; Recchia, G.; Dryhurst, S.; Sahlin, U.; Dufouil, C.; Arwidson, P.; Freeman, A. L. J.; van der Linden, S.
title: Predictors of COVID-19 vaccine acceptance across time and countries
date: 2020-12-11
journal: nan
DOI: 10.1101/2020.12.09.20246439
sha: 835bfa32215cbdf807dc7f7ac5739f3c875c0d80
doc_id: 1017100
cord_uid: jucs49di

Understanding the drivers of vaccine acceptance is crucial to the success of COVID-19 mass vaccination campaigns. Across 25 national samples from 12 different countries we examined the psychological correlates of willingness to receive a COVID-19 vaccine (total N = 25,334), with a focus on risk perception and trust in a number of relevant actors, both in general and specifically regarding the COVID-19 pandemic. Male sex, trust in medical and scientific experts and worry about the virus emerge as the most consistent predictors of reported vaccine acceptance across countries. In a subset of samples we show that these effects are robust after controlling for attitudes towards vaccination in general. Our results indicate that the burden of trust largely rests on the shoulders of the scientific and medical community, with implications for how future COVID-19 vaccination information should be communicated to maximize uptake.

COVID-19 has resulted in over a million deaths globally, illness for millions more, and unprecedented social and economic disruption 1,2 . Many governments have signaled that mass vaccination against the virus is the most straightforward-and possibly only-route to normality and stability 3, 4 . While recent announcements of effective vaccines 5, 6 are promising, the wider impact of vaccines on preventing the spread of disease is also dependent on the uptake within a given population. In order to achieve 'herd immunity', enough people in a population must be immune to prevent the spread of a disease among non-immune individuals. The proportion varies depending on a number of factors including how infectious the contagion is, its prevalence in a population, and the variation in individual susceptibility or exposure to infection 7 . Estimates for the level of immunity required for COVID-19 herd immunity have ranged from 50% to 80% of the population, acquired through either natural infection and recovery, or through vaccination 8, 9 .

Vaccine hesitancy-defined as a delay in acceptance or refusal of vaccines despite availability 10 -poses a challenge to achieving herd immunity. If a sufficient number of people in a population reject vaccination-and herd immunity is not achieved-the virus will continue to circulate among susceptible individuals, including those who are unable to be vaccinated for medical reasons. The WHO identified vaccine hesitancy as one of the top 10 threats to global health in 2019 11 , and in the pressing context of COVID-19, understanding vaccine hesitancy has only grown in importance 12 .

COVID-19 vaccine intentions have typically only examined trust in one entity (e.g. government or hospitals); research to date has not considered the possible overlap between trust in the government, trust in science and medicine, and general social trust [23] [24] [25] . There is also a question over the extent to which vaccine acceptance is linked to mistrust in experts and authorities regarding COVID-19 in particular, or a more general lack of trust in these actors. In order to target communications specifically designed to satisfy the information needs of those who distrust official authorities, it is important to identify the precise agents that they distrust (and, ideally, why).

Beyond trust, the perceived threat or risk posed by a given disease has also been shown to predict vaccination attitudes. Models of health behavior, such as the Health Belief Model 26 and Protection Motivation Theory 27 , place the perceived risk or severity of a disease as a key driver of vaccination intentions (and other preventative health behaviors) 13, 28 . Recent surveys in the US, Malaysia, and Israel have shown that perceived risk and worry regarding the COVID-19 virus is associated with vaccine acceptance [29] [30] [31] . Other factors, such as the perceived benefits and costs as well as efficacy of protective behaviors are also outlined in models of health behavior as predictors of engagement in a given health behavior. However, until recently, little information about the possible costs, distribution and efficacy of a COVID-19 vaccine was available, meaning that the public has not generally been able to assess the potential benefits of a vaccine outside of a purely hypothetical arena (although experimental work has examined the influence of these factors on willingness to receive a vaccine 32 ).

There are also increasing concerns about the politicization of science and about politics becoming entangled with vaccine beliefs and attitudes specifically, particularly in the context of a pandemic where central government structures are deeply involved in all stages of the public health response 13, 33 . Prior research 34 has shown that the rhetoric adopted by political elites on social media can fuel anti-vaccination attitudes amongst their followers and that ideologies can help explain anti-vaccination attitudes 30, 35 .

In the current study we present a more comprehensive international analysis of the role of key social, political, and psychological predictors of COVID-19 vaccine acceptance across 12 countries, with multiple national surveys in some countries (total N = 25,334, see Table 1 ). All samples were recruited via online panel providers using quotas to ensure samples were matched to the general population in terms of age and gender (with the exception of France, see methods). Unlike previous studies, we examine reported trust in a range of actors, both in general and specifically relating to the COVID-19 pandemic. We also include several demographic factors (including politics), numeracy (known to play a role in risk perceptions 36 , and vaccine attitudes in particular 37 ), affective (worry) and cognitive (perceived likelihood of infection) aspects of perceived COVID-19 risk 38 , broad measures of perceived efficacy, and, in a subset of samples, general attitudes towards vaccines.

Between March and October 2020, we fielded 25 separate surveys across 12 countries. The majority of samples were recruited through an ISO certified international survey company Respondi (respondi.com). Participants in Australia were recruited through Dynata (dynata.com), and additional US and UK samples were recruited via Prolific (prolific.ac). Quota-based sampling ensured all samples were representative of the country population in terms of age and gender, and, in Prolific samples, ethnicity 39 . Participants who had previously completed a survey were prevented from completing further surveys, so all our samples represent different individuals. Demographic details for each sample are shown in Table 1 . For completeness we include several samples in which vaccine acceptance was . CC-BY-NC 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.09.20246439 doi: medRxiv preprint measured, but the survey did not always include all the predictor variables used in models presented below. Surveys which did not include all predictor variables are marked with a '*' in Table 1 . We also asked participants to report their trust in several actors with specific regard to the COVID-19 pandemic. Participants reported the extent to which they trust politicians in their country to 'deal effectively with the pandemic', and how much they separately trusted the country's national scientific and medical advisors, independent experts not connected . CC-BY-NC 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.09.20246439 doi: medRxiv preprint with government, and the WHO to 'know the best measures to take in the face of the pandemic' (all from Not at all to Very much). Personal and government efficacy were captured by items asking participants the extent to which they felt that, respectively, their own actions, and the actions of their country 'to limit the spread of coronavirus can make a difference' (Not at all to Very much). Perceived likelihood of infection was measured as an index of three related items (example: I will probably get sick with the coronavirus/COVID- Table S1 .

Surveys were translated from English to other languages by native speakers fluent in English. Multi-item scales (trust in science, trust in government and perceived likelihood of infection) were subjected to multi-group confirmatory factor analysis to establish measurement invariance 43 . All scales exhibited metric invariance based on a criterion of a reduction in CFI no greater than .02 when constraining item factor loadings to be equal across different countries (see Table S2 ). This more relaxed criterion (compared to the widely used ΔCFI < .01 43 ) was applied in light of the recommendations of Rutkowski and Svetina 44 for analyses with a large number of groups. Metric invariance indicates that effects of the construct in question (but necessarily not latent means) can be compared across groups. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.09.20246439 doi: medRxiv preprint Figure 1 shows the percentage of participants in each survey who responded that they would be willing to be vaccinated if a COVID-19 vaccine was available, or would recommend a vaccine to vulnerable others, given the options of 'Yes' or 'No' 1 . Across all samples, the percentage of respondents who stated they were willing to receive a vaccine ranged from 62.6% (Sweden, April) to 88.1% (Mexico, March), while the percentage of those who said they would recommend a vaccine to vulnerable others ranged from 67.5% (US, September) to 91.7% (UK, March). Descriptively, in every single sample the proportion of respondents stating a willingness to receive a vaccine was lower than the proportion who would recommend it to vulnerable others (Mdiff = -5.79%, SD = 3.00). We also note a trend of decreasing stated acceptance over time: in nearly all countries with multiple samples, vaccine acceptance in any given survey was lower than previous surveys of the same population. For example between March and May, 2020, stated vaccine acceptance among respondents in Mexico dropped from 88.1% to 73.9% (a two-sample proportion test indicated that this difference was statistically significant, 95%CI [-18.4%, -9.9%], z = 6.51, p < .001) In the US, stated vaccine acceptance (among participants recruited through online panel provider Respondi) fell more than 12 percentage points, from 74.7% to 62.6%, between May and September, 2020 (95%CI [-16.7%, -7.5%], z = 5.09, p < .001) 1 Based on respondents who answered the question. In the Italy sample a number of participants were not presented with these items due to a technical error (n = 80, 11%). In the remaining samples the average proportion of missing responses for vaccine intention and recommendation items was 1%. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.09.20246439 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.09.20246439 doi: medRxiv preprint We fitted a logistic regression model to data from each sample to identify the correlates of COVID-19 vaccine intentions. Predictors included: demographic variables; an objective measure of numeracy, political ideology; general social trust; prosociality (willingness to 'do things for the benefit of others and society' even at personal cost); general trust in medical and scientific experts; general trust in government; specific trust in politicians to manage the pandemic; specific trust in (separately) national science advisors, is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.09.20246439 doi: medRxiv preprint independent scientists and the WHO to 'know the best measures to take in the face of the pandemic'; the perceived efficacy of their own and their country's actions to limit the spread of the virus; perceived likelihood of infection; and, worry about COVID-19 (for details on measures see Methods section and Table S1 ; descriptive statistics are reported in Tables S3 and S4, ad bivariate correlations in Figure S1 ). Continuous measures (i.e. all except gender) were scaled and mean centered prior to analysis. Multicollinearity analyses indicated no issues arising from correlated predictors (all variance inflation factor values < 4). To facilitate the interpretation of results we present odds ratios in a heat map format in Figure 2 .

A full table of model results including confidence intervals can be found in Tables S5 and S6.

Results of models predicting vaccine recommendation responses are also presented in supplementary materials ( Figure S2 , Tables S7 and S8). is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.09.20246439 doi: medRxiv preprint such as the role of age, gender, and prosociality played a significant role. There was also variation over time. For example, although political ideology was not a significant predictor in the UK in May or July, conservatism was associated with lower vaccination intentions from September onwards (ORs 0.84-.88), which may be related to increased polarization. To illustrate the increasing strength of the association between political ideology and vaccine 2 UK data was over represented in our pooled sample. As a robustness check we also fitted the model to the pooled sample with UK data removed and report that the effects of gender, trust in experts and worry remain significant (ps < .001; see Table S5 ). is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.09.20246439 doi: medRxiv preprint acceptance over time in the UK, in Figure 3 we plot the predicted likelihood of reported vaccine acceptance across the political spectrum (holding all other predictors constant).

In the UK, we also report a different pattern of effects when comparing between samples collected via different providers, even where these were collected on the same day (in May, July, and September), were matched on age and gender, and controlling for a range of other demographic variables. This underscores the caution that must be applied when studies generalize results from a single survey sample (particularly an online survey).

In terms of variance explained, the variables in our model explained approximately 10-30% of the variance in the likelihood of vaccine acceptance vs refusal, with the exception of samples recruited in Korea (4%) and Japan (8%). is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.09.20246439 doi: medRxiv preprint

To examine the extent to which the effects in our model can be accounted for by a negative perception of vaccines in general, we conducted an additional set of analyses. In our three most recent UK surveys we included a two-item measure of general vaccine attitudes is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.09.20246439 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.09.20246439 doi: medRxiv preprint

Understanding the psychological determinants of vaccine acceptance and hesitancy is crucial during a global pandemic. Across all countries surveyed, between March and September 2020, a substantial proportion of participants (up to 37% in some countries) said that they would not accept a hypothetical COVID-19 vaccine. People were slightly more likely to say that they would recommend it to vulnerable friends and family members.

Considering who is more or less likely to report willingness to be vaccinated against COVID- Accounting for the other factors in our model, we find that trust in government (both generally and regarding COVID-19) and general social trust (i.e. trust in people) are not significantly associated with vaccine acceptance in most of our samples.

The fact that we saw only a weak link between stated vaccine acceptance and our measure of prosociality-along with the fact that higher numbers of people said that they'd recommend the vaccine to a vulnerable friend or relative than say they would accept it themselves-suggests that the prosocial nature of vaccines may not be recognized by many people. Recent experimental research has shown that emphasizing the societal benefits of is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.09.20246439 doi: medRxiv preprint herd immunity (i.e., the need for those who do not see themselves as personally vulnerable to take the vaccine in order to provide protection for those who are) may assist uptake 46 .

The higher reluctance from women to say that they would take a vaccine is in line with other work focusing on acceptance of a potential COVID-19 vaccine 14 Although international research has suggested that political conservatism is correlated with anti-vaccination attitudes globally 33 , we did not find that ideology was associated with vaccine acceptance outside of the US and UK. However most other countries were only surveyed in earlier stages of the pandemic (i.e. prior to May, 2020) and we can therefore not say whether they might have followed a similar pattern to the UK as time went on. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.09.20246439 doi: medRxiv preprint It is possible that misinformation susceptibility 48,49 and conspiracy thinking 50 underlie the association between ideology and vaccine attitudes to some extent. For example, Motta et al. 51 find that far right-wing media outlets have disproportionally spread misinformation during the early stages of the pandemic. Susceptibility to misinformation around COVID-19 was also found in prior research to be associated with measures of vaccine hesitancy 49 . There is already a proliferation of conspiracy theories focused on specific COVID-19 vaccines 52,53 .

It will be important to tackle these pro-actively through 'prebunking' methods to inoculate against misinformation 54,55 .

Finally, we acknowledge that the heterogeneity in our results across time and countries highlights the role that (unmeasured) contextual, country-specific factors play in informing individuals' vaccination attitudes. As noted by the WHO SAGE working group on vaccine hesitancy, individual factors such as trust and risk perception intersect with contextual influences such as culture, media environments, and information from local leaders 10 . Lastly, our samples were not truly representative of the general population in each country: although they were quota-balanced on gender and age, the population that respond to an online questionnaire will differ from the general population on several significant characteristics. However, the rank ordering of countries on vaccine acceptance in our study is similar to that of Lazarus et al 10 , which were based on a random stratified sampling approach using several online panel providers. This gives us some confidence in the generalizability of our results, and the fact that our samples were generally larger and included more trustfocused questions makes them useful for exploring these important predictors of vaccine attitudes.

In terms of practical considerations, our finding that trust in scientific and medical institutions is one of the strongest predictors of vaccine acceptance highlights the need to work proactively with others from outside of this sphere, such as community and religious is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.09.20246439 doi: medRxiv preprint leaders 56 to open a two-way conversation with those who distrust the scientific and medical establishment. Due consideration must also be given to the accessibility 57 , format 58,59 , and transparency 60,61 of information provided to the public. Future research should continue to evaluate how to most effectively communicate evidence about vaccination, and should seek to more deeply understand the concerns and needs of those who express hesitancy regarding COVID-19 vaccination. As Bhopal 62 , commenting on potential COVID-19 mass vaccination efforts, writes, "Open, honest, factual and sensitively conducted public dialogue is now urgent."

Countries around the world face a major evidence communication challenge when it comes to the COVID-19 vaccines that are about to become available. In order to reach a large enough proportion of the population in each country to achieve herd immunity, it is vital to increase in the number of people who are willing to take a vaccine. To achieve this, nonpharmaceutical interventions will need to be deployed 63 We recommend that empirical studies should continue to be carried out alongside qualitative work with different communities to get a rounded understanding of people's concerns and misunderstandings. Only by knowing these can we adequately address them and provide people with the information they need to make a decision that will affect not just their own health, but that of their community as well. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.09.20246439 doi: medRxiv preprint

The data and analysis code for this study are available at: is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.09.20246439 doi: medRxiv preprint To what extent do you feel that the personal actions you are taking to try to limit the spread of coronavirus make a difference? 1 = Not at all, 7 = Very much

To what extent do you feel the actions that your country is taking to limit the spread of coronavirus make a difference?

Perceived infection risk (scale) How likely do you think it is that you will be directly and personally affected by the following in the next 6 months? -Catching the coronavirus/COVID-19

1= Not at all likely, 7 = Very likely How likely do you think it is that your friends and family in the country you are currently living in will be directly affected by the following in the next 6 months? -Catching the coronavirus/COVID-19

1= Not at all likely, 7 = Very likely How much do you agree or disagree with the following statements? -I will probably get sick with the coronavirus/COVID-19. Table S3 Descriptive statistics for all samples (Mean (SD)), excluding US and UK samples (see Table S4 -

a Education item in France differed from other surveyssee Table S1 . is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.09.20246439 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.09.20246439 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.09.20246439 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.09.20246439 doi: medRxiv preprint 35 Figure S1 . Point biserial correlations between predictors and vaccine acceptance across all samples. Greyed values are non-significant (p > .05). Blank spaces indicate predictors which were not included in a given survey. Figure S2 . Heatmap of odds ratios in model predicting recommending vaccine to vulnerable friends/family. Columns represent individual samples and rows represent predictors in model. Grey values are non-significant, p > .05. Red shading indicates a lower likelihood of vaccine acceptance and blue shading a higher likelihood. For space, samples are defined by their two character ISO country code and a letter denoting participant source (D, Dynata; R, Respondi; P, Prolific). is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.09.20246439 doi: medRxiv preprint Table S9 Result of logistic regression models predicting vaccine acceptance, including or excluding general vaccine attitudes. 

COVID has killed more than one million people. How many more will die?

A Long and Difficult Ascent

Lockdowns and the COVID-19 pandemic: What is the endgame?

The public's role in COVID-19 vaccination: human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States

What Pfizer's landmark COVID vaccine results mean for the pandemic

COVID vaccine excitement builds as Moderna reports third positive result

Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold

High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2. Emerg

COVID-19 herd immunity: where are we?

Report of the Sage Working Group on Vaccine Hesitancy

Ten threats to global health in 2019

Restoring confidence in vaccines in the COVID-19 era

Social and political determinants of vaccine hesitancy: Lessons learned from the H1N1 pandemic of 2009-2010

A global survey of potential acceptance of a COVID-19 vaccine

Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China